Scleromyxedema, a therapeutic dilemma

Julio Cesar Salas-Alanis, Brayant Martinez-Jaramillo, Minerva Gomez-Flores, Jorge Ocampo-Candiani

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

© 2015, Medical Knowledge. All rights reserved. Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.
Original languageEnglish
Pages (from-to)215
Number of pages1
JournalIndian Journal of Dermatology
DOIs
Publication statusPublished - 1 Jan 2015

Fingerprint

Scleromyxedema
Thalidomide
Paraproteinemias
Melphalan
Leprosy
Immunoglobulins
Thorax
Stem Cells
Extremities
Therapeutics
Pharmaceutical Preparations

Cite this

Salas-Alanis, J. C., Martinez-Jaramillo, B., Gomez-Flores, M., & Ocampo-Candiani, J. (2015). Scleromyxedema, a therapeutic dilemma. Indian Journal of Dermatology, 215. https://doi.org/10.4103/0019-5154.152600
Salas-Alanis, Julio Cesar ; Martinez-Jaramillo, Brayant ; Gomez-Flores, Minerva ; Ocampo-Candiani, Jorge. / Scleromyxedema, a therapeutic dilemma. In: Indian Journal of Dermatology. 2015 ; pp. 215.
@article{e93c7ce58c6242d693ea045eca38b4a9,
title = "Scleromyxedema, a therapeutic dilemma",
abstract = "{\circledC} 2015, Medical Knowledge. All rights reserved. Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.",
author = "Salas-Alanis, {Julio Cesar} and Brayant Martinez-Jaramillo and Minerva Gomez-Flores and Jorge Ocampo-Candiani",
year = "2015",
month = "1",
day = "1",
doi = "10.4103/0019-5154.152600",
language = "English",
pages = "215",
journal = "Indian Journal of Dermatology",
issn = "0019-5154",
publisher = "Medknow Publications and Media Pvt. Ltd",

}

Salas-Alanis, JC, Martinez-Jaramillo, B, Gomez-Flores, M & Ocampo-Candiani, J 2015, 'Scleromyxedema, a therapeutic dilemma', Indian Journal of Dermatology, pp. 215. https://doi.org/10.4103/0019-5154.152600

Scleromyxedema, a therapeutic dilemma. / Salas-Alanis, Julio Cesar; Martinez-Jaramillo, Brayant; Gomez-Flores, Minerva; Ocampo-Candiani, Jorge.

In: Indian Journal of Dermatology, 01.01.2015, p. 215.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Scleromyxedema, a therapeutic dilemma

AU - Salas-Alanis, Julio Cesar

AU - Martinez-Jaramillo, Brayant

AU - Gomez-Flores, Minerva

AU - Ocampo-Candiani, Jorge

PY - 2015/1/1

Y1 - 2015/1/1

N2 - © 2015, Medical Knowledge. All rights reserved. Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.

AB - © 2015, Medical Knowledge. All rights reserved. Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.

U2 - 10.4103/0019-5154.152600

DO - 10.4103/0019-5154.152600

M3 - Article

SP - 215

JO - Indian Journal of Dermatology

JF - Indian Journal of Dermatology

SN - 0019-5154

ER -

Salas-Alanis JC, Martinez-Jaramillo B, Gomez-Flores M, Ocampo-Candiani J. Scleromyxedema, a therapeutic dilemma. Indian Journal of Dermatology. 2015 Jan 1;215. https://doi.org/10.4103/0019-5154.152600